Integra to Develop Short Stem and Stemless Shoulder System

Integra LifeSciences Holdings Corporation, a global medical technology company, has signed a license and development agreement with Consortium of Focused Orthopedists, LLC (CFO), for a short stem and stemless shoulder system. This is a key addition to Integra’s Extremity Orthopedics portfolio in a fast-growing segment of the shoulder arthroplasty market and is expected to accelerate growth opportunities globally.
 
The patent-pending design of the bone-sparing shoulder system will be competitively differentiated, with design features that address limitations of systems currently on the market.
 
“We designed this system to allow for patients to be anatomically suited to experience the bone-sparing benefits of a short stem,” said Dr. Armodios Hatzidakis, orthopedic surgeon, Western Orthopaedics, and one of the design surgeons with CFO. “Integra is a proven leader in medical devices with a successful track record of commercializing innovative products that improve patients’ lives. They are a logical choice to partner with to bring this product to market.”
 
“We are excited to partner with these leading shoulder surgeons from CFO—on this technology,” said Robert T. Davis, Jr., corporate vice president and president, Orthopedics and Tissue Technologies. “With the addition of a short stem and stemless shoulder system, we will have a competitive design in a large and fast-growing segment of shoulder arthroplasty. It expands on the strong product foundation of our Titan Modular Shoulder System and allows us to improve the shoulder arthroplasty experience for both surgeons and their patients.”
 
The following CFO orthopedic surgeons are industry thought leaders and pioneers in the development of shoulder implants and have contributed to the implant design of this short stem and stemless shoulder system: Dr. Armodios Hatzidakis, Western Orthopaedics; Dr. Heinz Hoenecke, Scripps Clinic; Dr. Scott Jacobson, The Center for Orthopedic and Neurosurgical Care and Research; Dr. James Kelly II, California Pacific Orthopaedics; and Dr. Drew Miller, Resurgens Orthopaedics. In addition to these CFO surgeons, there will be other leading surgeons who will contribute to the design of this new system.